Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

medmix AG

medmix AG

Actions
Health CareMedical Equipment and Services
  • Price (CHF)10.40
  • Today's Change0.22 / 2.16%
  • Shares traded73.66k
  • 1 Year change-53.78%
  • Beta--
Data delayed at least 15 minutes, as of Sep 27 2024 16:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medmix Systems AG is a Switzerland-based company active in manufacturing of high-precision delivery devices. The Company operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

  • Revenue in CHF (TTM)479.70m
  • Net income in CHF-1.80m
  • Incorporated2021
  • Employees2.70k
  • Location
    medmix AGNeuhofstrasse 20BAAR 6340SwitzerlandCHE
  • Phone+41 417237300
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tristel Plc44.39m6.79m220.43m213.0031.526.0322.924.970.12560.12560.82190.65670.9921.516.26185,394.4015.178.8617.1010.2482.5980.6315.2910.633.93411.730.1605109.9915.7010.14351.986.409.8818.05
Nyxoah SA4.50m-40.85m233.26m147.00--2.39--51.88-1.49-1.490.16423.500.0330.57592.1632,643.05-29.96-23.73-33.61-25.9862.4862.42-908.49-1,469.595.16--0.0959--40.99---38.39--100.58--
Detection Technology Oyj-93.83bn-93.83bn256.91m464.00--3.51----------5.03----------9.34--11.96--47.44--8.223.39--0.0053.455.292.027.55-18.03-14.88-9.55
Medistim ASA43.09m8.35m260.05m152.0031.068.4625.096.035.705.7029.4120.931.170.73196.343,542,250.0022.7122.9327.5928.5279.4978.2519.3820.642.40--0.026275.257.0010.06-8.9112.720.03314.87
COLTENE Holding AG238.80m12.34m287.67m1.19k24.543.0214.981.202.062.0639.8916.731.271.386.06198,668.906.5510.4811.7018.7464.9062.685.177.470.861910.180.342179.94-9.133.54-54.05-6.81-7.72-7.79
Synektik SA135.76m17.44m303.33m164.0020.339.4315.592.239.329.3272.5420.092.0316.347.224,043,567.0026.0410.2441.6515.7926.6522.8612.858.851.2813.970.090947.00167.81--409.18------
BICO Group AB187.64m-65.55m320.96m828.00--1.06--1.71-11.15-15.2031.9241.790.36022.154.472,547,964.00-12.62---14.44--55.70---35.03--2.23-0.57050.397--6.09---1,889.33------
IVF Hartmann Holding AG152.90m17.64m325.32m298.0018.642.3313.892.137.357.3563.7258.840.87883.148.52502,947.4010.147.2912.068.9055.2153.2911.548.303.95--0.005852.16-1.792.0934.951.49-14.8326.82
RaySearch Laboratories AB (publ)94.02m12.60m363.93m403.0034.256.7410.403.874.414.4132.9122.410.57014.503.112,901,244.007.641.2911.801.8890.4890.5713.402.551.17--0.393769.0021.1610.26243.060.7648-1.31--
Ion Beam Applications SA437.03m7.37m379.04m1.84k49.624.3120.600.86730.26890.268915.993.090.77212.152.70234,517.101.301.556.014.3234.1935.231.692.380.63723.770.399264.8318.6710.74-250.40---8.06--
medmix AG479.70m-1.80m396.46m2.70k--0.92046.880.8265-0.05-0.0511.3511.300.47783.405.58180,474.00-0.09962.06-0.12272.4932.5836.38-0.20854.161.062.210.436167.701.991.40-97.41-64.3612.01--
Guerbet SA737.25m22.39m415.56m2.92k20.681.245.320.56371.801.8062.1529.970.79970.59835.80269,071.902.261.402.961.8678.0176.022.821.821.215.620.503557.824.30-0.0993158.05-12.615.23-10.07
Stratec SE240.20m13.68m462.99m1.46k36.622.3514.701.931.201.2021.0618.710.58411.365.23168,187.303.337.074.228.2027.0827.325.699.700.94014.720.397640.81-4.636.88-55.293.30-2.16-7.68
Surgical Science Sweden AB69.83m16.47m499.45m265.0032.651.4123.487.153.873.8716.4390.020.16951.497.353,224,027.004.004.494.264.7868.5170.0623.5923.753.46--0.000.0010.0168.1424.47--38.57--
CellaVision AB60.51m12.08m528.54m221.0047.039.2334.028.736.086.0830.4531.000.7831.766.663,185,965.0015.6415.3018.1818.2466.6269.0319.9719.981.99103.580.0574110.185.9413.1710.128.0030.458.45
Advanced Medical Solutions Group plc147.39m12.52m555.33m1.50k43.621.9921.993.770.0510.0510.60111.120.39771.704.91154,244.703.386.543.647.0654.4556.758.4914.826.80--0.270225.851.514.23-22.14-6.7115.6612.32
Data as of Sep 27 2024. Currency figures normalised to medmix AG's reporting currency: Swiss Franc CHF

Institutional shareholders

20.08%Per cent of shares held by top holders
HolderShares% Held
Capital Research & Management Co. (World Investors)as of 18 Aug 20231.25m3.03%
Credit Suisse Asset Management (Schweiz) AGas of 09 Mar 20231.23m2.99%
UBS Asset Management Switzerland AGas of 26 Jan 20241.23m2.99%
Fidelity Investments Canada ULCas of 30 Jun 20241.10m2.68%
The Vanguard Group, Inc.as of 04 Jul 2024885.37k2.15%
Harris Associates LPas of 30 Jun 2024833.40k2.02%
Oddo BHF Asset Management SASas of 28 Jun 2024576.92k1.40%
Dimensional Fund Advisors LPas of 04 Jul 2024416.38k1.01%
Norges Bank Investment Managementas of 31 Dec 2023386.21k0.94%
WCM Investment Management LLCas of 31 Mar 2024365.68k0.89%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.